IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
17 hedge funds and large institutions have $1.49M invested in Interpace Biosciences, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$37K |
2 |
Morgan Stanley
New York
|
-$26.8K |
3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$5K |
4 |
BlackRock
New York
|
-$418 |